CANCER AND LEUKEMIA GROUP B

描述(改编自申请人的摘要)：纽约 医院-康奈尔医疗中心(NYH-CMC)一直是 癌症和白血病B组，继续热情参与 这个合作小组的活动已经有40多年了。在最新的 赠款周期，NYH-CMC通过CALGB提供了大规模的应计项目 覆盖纽约大都会地区的附属网络。这是意料之中的 这个附属网络将扩展到医疗中心自己的 区域护理网络，因此增加了下一个周期的应计费用。在……里面 此外，纽约医院自1997年5月起开设了新的格林伯格医院 展馆，一座850,000平方英尺，776张床位，11层的医院建筑 在曼哈顿的罗斯福大道上建造；这是其主要的 现代化项目象征着医疗中心致力于 最先进的内科和外科肿瘤学患者护理进入下一阶段 千禧年。近年来，Nyh-CMC扩大了临床和研究范围。 对传统上感兴趣的恶性肿瘤和癌症领域的兴趣 控制模式。目前，Nyh-CMC有调查人员领导CALGB 结直肠癌第二期流行病学研究，世卫组织将加强 机构在集团出版物作者方面的良好记录。 NYH-CMC继续在集团行政管理中发挥领导作用 活动通过数据审计委员会参与，哪个CALGB委员会 在全国合作组数据质量方面处于领先地位 保证。Nyh-CMC有理由为其主要应计捐款感到自豪 对翻译研究方案和它的少数收益是很好的 领先于集团平均水平和区域人口参数。都是主干道 成员和附属CALGB的参与由CALGB核心团队协调 在Nhy-CMC。该机构也是开发高度 高效和复杂的计算系统，用于其CALGB数据管理。 作为CALGB活动的长期领先机构，自该组织 成立以来，Nyh-CMC现在期待着相应的资金支持 以其目前和预期的患者收益和科学水平 在即将到来的赠款周期中行政参与CALGB试验。

DESCRIPTION (adapted from the applicant's abstract): New York Hospital-Cornell Medical Center (NYH-CMC) has been a charter member of the Cancer and Leukemia Group B, with continuous enthusiastic participation in this cooperative group's activities for over 40 years. In the most recent grant cycle, NYH-CMC has provided large-scale accrual through a CALGB affiliate network covering the metropolitan New York area. It is expected that this affiliate network will expand into the medical center's own regional care network, hence augmenting accrual in the coming cycle. In addition, the New York Hospital has opened as of May 1997 its new Greenberg pavilion, an 850,000-square-foot, 776-bed, 11-story hospital building constructed over the FDR Drive in Manhattan; this cornerstone of its major modernization project is emblematic of the medical center's commitment to state-of-the-art medical and surgical oncology patient care into the next millennium. Recently, NYH-CMC has expanded its clinical and research interests from traditionally strong areas of interest malignancy and cancer control modalities. Currently, NYH-CMC has investigators leading CALGB studies in phase II epidemiology of colorectal cancer, who will augment the institution's strong track record in authorship of group publications. NYH-CMC continues to have a leadership role in group administrative activities through data audit committee participation, which CALGB committee has taken a leading role in national cooperative group data quality assurance. NYH-CMC is justifiably proud of its major accrual contributions to translational research protocols and its minority accrual which is well ahead of group averages and regional population parameters. Both main member and affiliate CALGB participation is coordinated by a CALGB Core Team at NHY-CMC. The institution is also a group leader in developing a highly efficient and sophisticated computing system for its CALGB data management. As a longstanding leading institution in CALGB activities since the group's inception, NYH-CMC is now looking forward to funding support commensurate with its current and anticipated level of patient accrual and scientific and administrative involvement in CALGB trials for the coming grant cycle.